ArticleJournal of nanobiotechnology2026
Piezoelectric scaffold with enhanced effect drives the healing of osteochondral defects through electromechanical-immune coupling.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- RMF-Activated Superparamagnetic Iron Oxide Nanoparticles Trigger Macrophage-Dependent Protection AgainstInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Silk fibroin scaffolds (SFCs) that exploit piezoelectricity for osteochondral repair have been hampered by both insufficient electromechanical output and a pro‑inflammatory joint microenvironment that erodes therapeutic efficacy. To overcome these barriers, we developed an intra‑articular implantable scaffold with enhanced piezoelectricity, called FENS@MF, via covalently integrating ultradispersible magnetic nanoparticles (MNPs) into SFCs via EDC/NHS crosslinking. Under magnetically controlled stimulation, FENS@MF generates an ~ 8.5‑fold increase in output voltage, a threefold enhancement in tensile strength, and undergoes only 15.65% degradation by protease XIV over 15 d, thereby sustaining potent electromechanical signaling. In vitro, it markedly upregulates chondrogenic (COL2, SOX9), osteogenic (RUNX2, BMP2), and angiogenic (VEGF, eNOS) markers, while inducing M1‑to‑M2 macrophage polarization to attenuate inflammation. In rat osteochondral defect models, FENS@MF outperforms conventional SFC and FENS scaffolds, achieving cartilage and subchondral bone regeneration with bone mineral density and trabecular thickness comparable to autologous grafts. FENS@MF enhances the piezoelectric effect by responding to the magnetic field (MF) and absorbing electromagnetic waves, and cooperates with magnetic stimulation and immune microenvironment regulation to achieve efficient osteochondral regeneration. Enhanced piezoelectric signals may drive SOX9-mediated chondrogenesis through activation of p38 MAPK phosphorylation (upregulation of COL2/ACAN) and trigger osteogenic differentiation through β-catenin nuclear translocation (upregulation of RUNX/BMP2).This study is the first to integrate the piezoelectric effect, magnetic stimulation and immunomodulation, which breaks through the limitation of a single functional scaffold, establishes a 'structure-function-signal' paradigm for intelligent osteochondral repair, and provides a multifunctional platform for functional tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.